PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples

Recruiting

Phase 2

Neoadjuvant ChemotherapyPurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples

Sponsor:

Medical College of Wisconsin

Code:

NCT04683315

Conditions

Pancreatic Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

mFOLFIRINOX Treatment Regimen

Gemcitabine/Nab-paclitaxel Treatment Regimen

Chemoradiation

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-27. This information was provided to ClinicalTrials.gov by Medical College of Wisconsin on 2024-11-21.